Reta glucagon-like peptide-1 (GLP-1) receptor agonists represent a groundbreaking strategy to diabetes management. These innovative drugs function by mimicking the inherent actions of GLP-1, a hormone secreted by the https://finnianumjq887982.ziblogs.com/39297450/reta-glucagon-like-peptide-1-receptor-agonists